FAST NEWS: Fosun Pharma’s Revenue Growth Slows Sharply in Third Quarter
The latest: Shanghai Fosun Pharmaceutical (Group) Co. Ltd. (2196.HK; 600196.SH) said Sunday its revenue increased 1.7% year-on-year to 10.27 billion yuan ($1.4 billion) in the third quarter, as measured using…
RELATED ARTICLES
-
Fosun Tourism at crossroads as parent shops its two major assets
1992.HK 0656.HK -
Fosun Tourism embarks on new journey with departure of big-name director
1992.HK
-
IFlytek hives off health unit to fund AI medical drive
002230.SHE
- Margins ring alarm bells as 160 Health readies IPO
-
Ping An Health pins recovery hopes on new leadership
1833.HK
